NVNONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
enVVeno Medical Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026
$7.69+0.22 (+2.95%)
Close on Oct 19, 2026
- Market cap
- $5.16M
- P/E (TTM)
- –
- Dividend yield
- –
enVVeno Medical Corp revenue by segment
By business segment
By product or service
| Revenue | FY2019 | FY2018 | FY2017 | % of revenue | YoY |
|---|---|---|---|---|---|
| Royalty Income [Member] | $31.24K | $116.15K | $137.71K | 100.0% | -73.1% |
| Product Sales [Member] | – | – | $184.80K | – | – |
| Contract Research - Related Party [Member] | – | $70.40K | $99.60K | – | – |
| Contract Research - Related Party [Member] | – | $70.40K | – | – | – |
By region
From the segment and revenue-disaggregation notes of enVVeno Medical's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.